{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:54:52Z","timestamp":1791266092758,"version":"4.1.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Reliable blood-based biomarkers are increasingly needed for the detection and monitoring of Alzheimer\u2019s disease (AD). Left\u2013right determination factor 2 (LEFTY2) is a secreted protein of the transforming growth factor-\u03b2 (TGF-\u03b2) superfamily. Evidence from AD-related neuronal models suggests that LEFTY2 promotes neuronal survival, attenuates amyloid- and tau-related pathology, and suppresses inflammatory responses, highlighting its potential relevance to AD. However, its clinical significance and relationship with AD-related blood biomarkers remain unclear. In this study, we investigated the association between serum LEFTY2 and and biomarkers associated with amyloid pathology, tau pathology, neuroinflammation, and neurodegeneration in patients with AD and age-matched cognitively normal (CN) controls. Biomarker levels were quantified using enzyme-linked immunosorbent assays. Serum LEFTY2 levels were significantly lower in AD patients than in cognitively normal controls, whereas Amyloid-beta 1\u201340 (A\u03b21-40), phosphorylated tau (pTau) 181 and Neurofilament light chain (NF-L) levels were significantly elevated. Correlation analyses revealed a positive association between LEFTY2 and A\u03b21-42 in AD patients, while correlations with biomarkers of tau pathology, inflammation, and neurodegeneration were less consistent. In cognitively normal controls, LEFTY2 was negatively correlated with total tau and positively correlated with TGF-\u03b21. Collectively, these findings indicate that LEFTY2 exhibits distinct associations with AD-related biomarkers in a disease-dependent manner. These exploratory findings provide new insights into the relationships among circulating AD biomarkers and support further investigation of LEFTY2 as a novel candidate blood-based marker in larger prospective cohorts.<\/jats:p>","DOI":"10.3389\/fnagi.2026.1955495","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:21:38Z","timestamp":1791264098000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reduced serum LEFTY2 and disease-dependent biomarker associations in Alzheimer\u2019s disease: an exploratory study"],"prefix":"10.3389","volume":"18","author":[{"given":"Wei","family":"Wuli","sequence":"first","affiliation":[{"name":"Bioinnovation Center, Hualien Tzu Chi Hospital","place":["Hualien, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Y.","family":"Lo","sequence":"additional","affiliation":[{"name":"Center for Dementia Care, St. Mary\u2019s Hospital","place":["Taitung, Taiwan"]},{"name":"Department of Biochemistry and Molecular Medicine, National Dong Hwa University","place":["Hualien, Taiwan"]},{"name":"Department of Neurology, Hualien Tzu Chi Hospital","place":["Hualien, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Jyh","family":"Harn","sequence":"additional","affiliation":[{"name":"Bioinnovation Center, Hualien Tzu Chi Hospital","place":["Hualien, Taiwan"]},{"name":"Department of Pathology, Hualien Tzu Chi Hospital","place":["Hualien, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzyy-Wen","family":"Chiou","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Medicine, National Dong Hwa University","place":["Hualien, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Xuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Bioinnovation Center, Hualien Tzu Chi Hospital","place":["Hualien, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuncin","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hualien Tzu Chi Hospital","place":["Hualien, Taiwan"]},{"name":"Ph.D. Program of Interdisciplinary Medicine, National Yang Ming Chiao Tung University","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Wijaya","sequence":"additional","affiliation":[{"name":"Bioinnovation Center, Hualien Tzu Chi Hospital","place":["Hualien, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinn-Zong","family":"Lin","sequence":"additional","affiliation":[{"name":"Bioinnovation Center, Hualien Tzu Chi Hospital","place":["Hualien, Taiwan"]},{"name":"Department of Neurosurgery, Hualien Tzu Chi Hospital","place":["Hualien, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"106790","DOI":"10.1016\/j.neubiorev.2026.106790","article-title":"Rethinking early Alzheimer's disease: an impaired internal model updating disorder?","volume":"188","author":"Antonioni","year":"2026","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00415-025-13498-y","article-title":"Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK biobank","volume":"272","author":"Buonocore","year":"2025","journal-title":"J. Neurol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.cub.2004.02.042","article-title":"Two modes by which lefty proteins inhibit nodal signaling","volume":"14","author":"Chen","year":"2004","journal-title":"Curr. Biol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/arclin\/acae019","article-title":"Plasma biomarkers for Alzheimer's and related dementias: a review and outlook for clinical neuropsychology","volume":"39","author":"Dark","year":"2024","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer disease: the amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease","volume":"18","author":"Hansson","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in Alzheimer disease","volume":"25","author":"Heneka","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41582-022-00665-2","article-title":"Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility","volume":"18","author":"Karikari","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref9011","article-title":"Figures created in BioRender","author":"Lab","year":"2026"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"fcz038","DOI":"10.1093\/braincomms\/fcz038","article-title":"Relationship of amyloid-beta1-42 in blood and brain amyloid: Ginkgo evaluation of memory study","volume":"2","author":"Lopez","year":"2020","journal-title":"Brain Commun."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41582-024-00989-1","article-title":"Alzheimer disease blood biomarkers: considerations for population-level use","volume":"20","author":"Mielke","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e70987","DOI":"10.1002\/alz.70987","article-title":"Plasma P-tau217, GFAP, and NfL as biomarkers for Alzheimer's disease: role in disease stratification, pathological progression, and cognitive decline","volume":"21","author":"Pan","year":"2025","journal-title":"Alzheimers Dement."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.14283\/jpad.2018.41","article-title":"Plasma Abeta42\/40 ratio detects early stages of Alzheimer's disease and correlates with CSF and neuroimaging biomarkers in the AB255 study","volume":"6","author":"Perez-Grijalba","year":"2019","journal-title":"J. Prev Alzheimers Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","article-title":"Biomarker-based staging of Alzheimer disease: rationale and clinical applications","volume":"20","author":"Therriault","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: results from the standardization of Alzheimer's blood biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.devcel.2009.02.012","article-title":"Tgf-beta superfamily signaling in embryonic development and homeostasis","volume":"16","author":"Wu","year":"2009","journal-title":"Dev. Cell"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.3390\/ijms26073382","article-title":"The therapeutic potential of ADSC-secreted LEFTY2 in treating Alzheimer's disease","volume":"26","author":"Wuli","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1038\/s41467-026-71269-3","article-title":"Plasma phosphorylated tau 217 and longitudinal trajectories of Abeta, tau, and cognition in cognitively unimpaired older adults","volume":"17","author":"Yang","year":"2026","journal-title":"Nat. Commun."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/alzrt163","article-title":"Plasma tau levels in Alzheimer's disease","volume":"5","author":"Zetterberg","year":"2013","journal-title":"Alzheimer's Res. Ther."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/biomedicines14020351","article-title":"New SPRi biosensors for simultaneous detection of tau protein isoforms-the importance of the Ptau181\/Total tau ratio in Alzheimer's disease","volume":"14","author":"Zielinska","year":"2026","journal-title":"Biomedicine"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1955495\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:21:39Z","timestamp":1791264099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1955495\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":22,"alternative-id":["10.3389\/fnagi.2026.1955495"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1955495","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"article-number":"1955495"}}